Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Warfarin vs Bridging for Small Polyp Resection
NCT02375646Unknown
- Sponsor
- Hadassah Medical Organization
- Start
- May 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
01
Overview
Randomised, single-blind trial of warfarin in venous thromboembolism (VTE) and Atrial fibrillation (AFib) (2 arms), sponsored by Hadassah Medical Organization. Primary endpoint: Post-polypectomy major bleeding rate at 2 weeks. Status: unknown.
02
Drugs
warfarin
03
Conditions
venous thromboembolism (VTE)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02375646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02375646.